Koller’s company, Insitro, in a matter of months raised over $100 million from big-name investors including ARCH, Foresite Capital, Andreessen Horowitz, and the firm that manages Jeff Bezos’ personal VC investments. Gilead Sciences has agreed a deal with machine-learning start-up Insitro to help the drug maker develop treatments for liver disease. Gilead will pay an initial $15m to the San Francisco-based start-up, with a potential $1bn in payments at later dates if certain targets are met. The company said it would use machine learning, which is used by many tech firms and big banks to make sense of huge amounts of data, as part of its efforts to improve treatment options for patients suffering
Gilead Sciences has agreed a deal with machine-learning start-up Insitro to help the drug maker develop treatments for liver disease. Gilead will pay an initial $15m to the San Francisco-based start-up, with a potential $1bn in payments at later dates if certain targets are met. The company said it would use machine learning, which is used by many tech firms and big banks to make sense of huge amounts of data, as part of its efforts to improve treatment options for patients suffering